Corpus Intelligence IC Memo — KINDRED HOSPITAL GREENSBORO 2026-04-26 06:36 UTC
IC Memo — KINDRED HOSPITAL GREENSBORO
Investment Committee Memorandum | NC | 101 beds | Grade C | EBITDA uplift $3.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KINDRED HOSPITAL GREENSBORO

CCN 342012 | GUILFORD, NC | 101 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KINDRED HOSPITAL GREENSBORO is a 101-bed suburban community hospital in GUILFORD, NC with $44.9M in net patient revenue and a 21.2% operating margin. The hospital serves a payer mix of 21.1% Medicare, 0.2% Medicaid, and 78.8% commercial.

Thesis: Turnaround. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 21.2% to 28.5% (+736bps).

Net Revenue HCRIS$44.9M
Current EBITDA COMPUTED$9.5M
Operating Margin COMPUTED21.2%
Occupancy HCRIS43.4%
Revenue / Bed COMPUTED$445K
Net-to-Gross HCRIS38.2%
Distress Probability ML50.4%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
58
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 21.2% places it above the state median. Among 58 size-comparable peers (50-202 beds), the median margin is -1.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-202), prioritizing same-state peers. 58 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KINDRED HOSPITAL GREENSBORO (Target)NC101$44.9M21.2%
DUKE RALEIGH HOSPITALNC186$683.0M3.7%
CATAWBA VALLEY MEDICAL CENTERNC200$451.9M5.9%
MARGARET R. PARDEE MEMORIAL HONC160$341.3M-5.7%
JOHNSTON HEALTHNC179$331.7M9.6%
WAKE MED CARY HOSPITALNC189$318.1M-3.6%
ATRIUM HEALTH UNIONNC183$302.3M7.0%
S.E. REGL MEDICAL CENTERNC179$298.1M-25.3%
ATRIUM HEALTH UNIVERSITY CITYNC104$286.9M28.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$944K+210bp18mo
Cost to Collect4.5%2.5%$899K+200bp12mo
Denial Rate Reduction12.0%6.5%$890K+198bp12mo
A/R Days Reduction5200.0%3800.0%$547K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$944K
Cost to Collect
$899K
Denial Rate Reduction
$890K
A/R Days Reduction
$547K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.3M
Current EBITDA$9.5M
+ RCM Uplift+$3.3M
Pro Forma EBITDA$12.8M
Current Margin21.2%
Pro Forma Margin28.5%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$14.6M$95.8M6.55x45.6%
Base (11x exit)10.0x11.0x$14.6M$110.1M7.53x49.7%
Bull Case9.0x11.0x$13.2M$125.8M9.56x57.0%
Bull (12x exit)9.0x12.0x$13.2M$141.1M10.72x60.7%
Bear Case11.0x10.0x$16.1M$74.5M4.63x35.9%
Bear (11x exit)11.0x11.0x$16.1M$87.2M5.42x40.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 58 hospitals with 50-202 beds
  • Same-state prioritization (n=59)
  • Comp margins: P25=-8.7% / P50=-1.5% / P75=6.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.